Fever as a Marker of Reactogenicity of an Acellular Pertussis-Containing Hexavalent Vaccine (HEXAVAC®) in a Large-Scale, Open, Randomized Safety Study in Healthy French Infants.

Zdroj: Human Vaccines; Sep2006, Vol. 2 Issue 5, p215-221, 7p
Databáze: Complementary Index
Externí odkaz: